Literature DB >> 17046551

Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong.

Samuel Yeung Shan Wong1, Dicken C C Chan, Athena Hong, Jean Woo.   

Abstract

The purpose of this investigation was to study the prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong. A community-based, cross-sectional household survey was performed in Hong Kong on men aged 45 to 64 years. Demographics, lifestyle information (cigarette smoking, alcohol consumption, and physical activity), and symptoms previously defined for identifying those with androgen deficiency were measured by using standardized questionnaires. Blood samples were collected in the morning, and total, free, and bioavailable testosterone levels were assessed. Data on androgen deficiency were available for 252 men aged 45 to 64 years. Crude prevalence of androgen deficiency was 9.52%. Prevalence increased significantly with age. For risk factors, having a lower personal income and having a history of hypertension were independently associated with increased risk of having androgen deficiency (odds ratio, 3.72; confidence interval, 1.01-13.61; and odds ratio, 2.89; confidence interval, 1.06-7.91, respectively). The prevalence of androgen deficiency in Hong Kong Chinese is similar to that found in Caucasians by using a similar definition. From this age-specific prevalence cross-sectional data, it is estimated that there are approximately 68,775 Hong Kong Chinese men aged 45-64 years with androgen deficiency. Future studies with large sample size are needed to evaluate the risk factors for androgen deficiency in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046551     DOI: 10.1016/j.metabol.2006.06.019

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Male sexual dysfunction in Asia.

Authors:  Christopher Ck Ho; Praveen Singam; Goh Eng Hong; Zulkifli Md Zainuddin
Journal:  Asian J Androl       Date:  2011-06-06       Impact factor: 3.285

2.  Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample.

Authors:  Susan A Hall; Gretchen R Esche; Andre B Araujo; Thomas G Travison; Richard V Clark; Rachel E Williams; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2008-07-29       Impact factor: 5.958

3.  Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis.

Authors:  Janet M Chiang; George A Kaysen; Mark Segal; Glenn M Chertow; Cynthia Delgado; Kirsten L Johansen
Journal:  Nephrol Dial Transplant       Date:  2019-05-01       Impact factor: 5.992

Review 4.  Testosterone and ill-health in aging men.

Authors:  Bu B Yeap
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

5.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

6.  Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study.

Authors:  Ayman A Al Hayek; Yousef S Khader; Sahar Jafal; Nahla Khawaja; Asirvatham A Robert; Kamel Ajlouni
Journal:  J Family Community Med       Date:  2013-09

Review 7.  Testosterone deficiency in adults and corresponding treatment patterns across the globe.

Authors:  James Anaissie; Kent J DeLay; William Wang; Georgios Hatzichristodoulou; Wayne J Hellstrom
Journal:  Transl Androl Urol       Date:  2017-04

8.  Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank.

Authors:  Richard J Fantus; Rong Na; Jun Wei; Zhuqing Shi; W Kyle Resurreccion; Joshua A Halpern; Omar Franco; Simon W Hayward; William B Isaacs; S Lilly Zheng; Jianfeng Xu; Brian T Helfand
Journal:  Eur Urol Open Sci       Date:  2021-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.